IDF21-0018 Patient Reported Outcomes for Tirzepatide versus Semaglutide in Participants with T2D from the SURPASS-2 Trial. (April 2022) - Boye, K.S.; Yu, M.; Liu, B.; Cui, X.; Bergman, B.; Fernández Landó, L.; Brown, K.